Scorpius BioManufacturing offers cell therapy process development services that span all phases of the product life cycle, from small-scale, proof-of-concept studies through commercial-scale cGMP-compliant manufacturing.
Scorpius' expert process development team has extensive experience in the isolation of cells from a variety of tissue sources, as well as the development of robust expansion and cell recovery processes for a number of cell and cell-gene cell lines. Whether you're seeking cell therapy process development for small-scale, preclinical evaluation and proof-of-concept studies or cGMP-compliant, clinical- or commercial-scale processes, Scorpius' PD services can bring clarity to your timeline and procedures.
The extensive process development capabilities offered at Scorpius' CDMO biomanufacturing facilities allow us to develop reproducible and scalable manufacturing processes to accelerate a client's clinical development program. Development programs typically include transition from open 2D culture systems to functionally closed 3D bioreactor systems, scale-out or scale-up to meet dosing requirements, optimization of cryopreservation and product comparability studies.